Minverva Biosciences Surrenders Some Of Earlier Gains - Minerva Neurosciences (NASDAQ:NERV)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Minverva Biosciences (NASDAQ: NERV) shares are trading higher by $6.30 at $9.84 in Thursday's session. The issue bolted to $15 in premarket trading after the announcement that MIN-101 monotherapy for depression meets primary and secondary endpoints before falling back to the $10 area.Off the open, it rallied to $$10.60 before some profit takers came in. The ensuing decline took it down to $8.25, but now is attempting the $10 handle.

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!